Assignee
IMMUNOME INC
US·10 granted patents·13 pending applications·3 citations·filing 2019–2025
Top patents by PatentIndex Score
23 records- 0190US12186403B2Immunoconjugates and methodsIMMUNOME INC·Filed 2023·Granted Jan 7, 2025·1 cites·30 claims
- 0287US12280121B2Immunoconjugates and methodsIMMUNOME INC·Filed 2024·Granted Apr 22, 2025·0 cites·12 claims
- 0387US12274754B2Immunoconjugates and methodsIMMUNOME INC·Filed 2024·Granted Apr 15, 2025·0 cites·12 claims
- 0486US12285492B2Immunoconjugates and methodsIMMUNOME INC·Filed 2024·Granted Apr 29, 2025·0 cites·13 claims
- 0586US12268750B2Immunoconjugates and methodsIMMUNOME INC·Filed 2024·Granted Apr 8, 2025·0 cites·3 claims
- 0682US12233072B2Compositions comprising bisfluoroalkyl-1,4-benzodiazepinone compounds for treating Adenoid Cystic CarcinomaIMMUNOME INC·Filed 2019·Granted Feb 25, 2025·1 cites·13 claims
- 0781US2024316062A1Combination of immunotherapeutics and bisfluoroalkyl-1,4-benzodiazepinone compounds for treating cancerIMMUNOME INC·Filed 2024·Application pending·0 cites
- 0879US12162945B2EPHA2 antibodiesIMMUNOME INC·Filed 2022·Granted Dec 10, 2024·1 cites·5 claims
- 0966US2025051464A1Epha2 antibodiesIMMUNOME INC·Filed 2024·Application pending·0 cites
- 1063US2024067704A1Antibody cocktail against sars-cov-2 spike proteinIMMUNOME INC·Filed 2023·Application pending·0 cites
- 1161US2025346565A1Methods of preparing chiral benzodiazepinone derivativesIMMUNOME INC·Filed 2025·Application pending·0 cites
- 1261US2026028319A1Intermediate salt for the preparation of bis(fluoroalkyl) benzodiazepinone compoundsIMMUNOME INC·Filed 2023·Application pending·0 cites
- 1359US2026021193A1Immunoconjugates and methodsIMMUNOME INC·Filed 2023·Application pending·0 cites
- 1458US12545716B2Immunoconjugates and methodsIMMUNOME INC·Filed 2022·Granted Feb 10, 2026·0 cites·18 claims
- 1558US2025276077A1Epha2 antibodiesIMMUNOME INC·Filed 2023·Application pending·0 cites
- 1656US12503449B2Methods of preparing chiral benzodiazepinone derivativesIMMUNOME INC·Filed 2021·Granted Dec 23, 2025·0 cites·21 claims
- 1756US11834493B2Antibody cocktail against SARS-CoV-2 spike proteinIMMUNOME INC·Filed 2022·Granted Dec 5, 2023·0 cites·35 claims
- 1853US2026028420A1Anti-tumor antibodiesIMMUNOME INC·Filed 2023·Application pending·0 cites
- 1950US2024174741A1Il-38-specific antibodiesIMMUNOME INC·Filed 2022·Application pending·0 cites
- 2042US2021221914A1Ch3 domain epitope tagsIMMUNOME INC·Filed 2019·Application pending·0 cites
- 2141US2022002435A1Antibodies targeting epn1IMMUNOME INC·Filed 2019·Application pending·0 cites
- 2240US2021347895A1Exosome-targeting bispecific antibodiesIMMUNOME INC·Filed 2019·Application pending·0 cites
- 2339US2022275077A1Il-38-specific antibodiesIMMUNOME INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when IMMUNOME INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →